Chronic kidney disease (CKD), a progressive loss of kidney function, is prevalent among 9.1% of the global population and 28% of older adults.
1,2 It presents both as a direct cause of mortality as well as a consequence and risk factor of several diseases, and up to 2.6 million deaths worldwide in 2017 were estimated to have been attributable to CKD.
1 Timely detection and management of kidney function deterioration can reduce progression of CKD to more severe forms, including end-stage kidney disease. However, the measurement of glomerular filtration rate (GFR), the criterion standard for assessing kidney function, is cumbersome and unfeasible for screening purposes. Indeed, obtaining measures of GFR using the clearance of exogenous filtration markers, such as iohexol, is complex and not routinely performed outside specialized settings.